Coagulation alterations due to local fibrinolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease

CardioVascular and Interventional Radiology

Volumn 20, Issue 3, 1997, Pages 169-173

  Rauber, Klaus ^a   Heidinger, Kathrin S ^a   Kemkes Matthes, Bettina ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Arterial occlusive disease; Coagulation disorders; rt PA; Thrombolysis

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTERY CATHETER; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FIBRINOGENOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY;

AGED; BLOOD COAGULATION; CASE-CONTROL STUDIES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEPARIN; HUMANS; PERIPHERAL VASCULAR DISEASES; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031001045     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002709900131     Document Type: Article

References (26)

1. Hess H, Mietaschk A, Bruckl R (1987) Peripheral arterial occlusions: A 6-year experience with local low-dose thrombolytic therapy. Radiology 163:753-758
2. Roth FJ, Rieser R, Scheffler A, Krings W (1991) Intra-arterial fibrinolytic therapy of chronic arterial occlusion. Semin Thromb Hemost 17:39-47
3. Hoylaerts M, Rijken DC, Lijnen H, Collen D (1982) Kinetics of the activation of plasminogen by human tissue-type plasminogen activator: Role of fibrin. J Biol Chem 257:2912-2919
4. Collen D, Lijnen HR (1986) Tissue type plasminogen activator: Mechanism of action and thrombolytic properties. Haemostasis 16:25-32
5. Camiolo SM, Thorsen S, Astrup T (1971) Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc Soc Exp Biol Med (NY) 138:277-280
6. Rijken DC, van Hinsbergh VWM, Sens EHC (1984) Quantitation of tissue plasminogen activator in endothelial cultures by use of an enzyme immunoassay. Thromb Res 33:145-153
7. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AW, Elms M, Bunce IS, Webber AJ, et al. (1983) An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31:767-778
8. Von Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237-246
9. Weimar W, Stibbe J, Seyen AJ, van Billian A, de Somer P, Collen D (1981) Specific lysis of an iliofemoral thrombus by administration of extensive (tissue-type) plasminogen activator. Lancet 11:1018-1020
10. Dechend R, Selbig D, Praus M, Hauck S, Dietz R, Gulba DC (1995) Long-term thrombolytic therapy in submassive pulmonary embolism: Results of a pilot study with two new thrombolytic rt-PA regimens. Ann Hematol 70[suppl]:93
11. Yang G, Green D (1990) Plasminogen, alpha 2-antiplasmin and protein C decline following infusions of recombinant tissue plasminogen activator. Semin Thromb Hemost 16:242-243
12. Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE, Leinbach RC, Brinker JA, Ludbrook PA, Yasuda I (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator. A prospective, randomized, placebo-controlled trial. Circulation 70:1012-1017
13. Garabedian HD, Gold HK, Leinbach RC, Yasuda T, Johns J, Collen D (1986) Dose-dependent thrombolysis, pharmakokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis. Am J Cardiol 58:673-679
14. Meyerowitz MF, Goldhaber SZ, Reagan K, Polak JF, Kandarpa K, Grassi CJ, Donovan BC, Bettmann MA, Harrington DP (1990) Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusion: A randomized trial. Radiology 175:75-78
15. Garcia-Avello A, Garcia-Frade LJ, Gandarias C, Ocana J, Cancelas JA, Lasso M (1994) High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA. Thromb Res 73:109-115
16. Koppensteiner R, Speiser W, Minar E, Ahmadi R, Ehringer H (1990) D-Dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease. Thromb Hemost 64:192-195
17. Franks JJ, Kirsch RE, Kao B, Kloppel TM (1984) Fibrinogen and fibrinogen-related peptides in cancer. In: Mariani D (ed): Pathophysiology of Plasma Protein Metabolism. Macmillan, London, pp 265-269
18. Klein P, Roth FJ, Rieger H, Popov-Cenic S (1992) Änderungen systemischer Fibrinolyse- und Gerinnungsparameter während der lokalen Lyse mit Tissue Plasminogen Activator (rt-PA). Vasa 21:249-252
19. Rijken DC, Juhan-Vague I, De Cock F, Collen D (1983) Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. J Lab Clin Med 101:274-284
20. Korninger C, Stassen JM, Collen D (1981) Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits. Thromb Hemost 46:658-661
21. Shi Y, Nardone D, Hernandez-Martinez A, Walinsky P, Bjornsson TD, Zalewski A (1992) Fibrinolytic activity after vessel wall injury. J Am Coll Cardiol 19:441-443
22. Tanigawa M, Wada H, Minamikawa K, Wakita Y, Nagay S, Mori T, Tamaki S, Nishikawa H, Kakuta Y, Nakano T (1995) Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am J Hematol 49:1-5
23. Schulman S, Granqvist S, Wiman B, Lockner D (1985) Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis. Thromb Res 39:607-612
24. Kirchmaier CM, Lindhoff-Last E, Rübesam D, Scharrer I, Vigh Z, Wolf H, Breddin HK (1994) Regression of deep vein thrombosis by i.v. administration of a low molecular weight heparin: Results of a pilot study. Thromb Res 73:337-348
25. Grulich-Henn J, Preissner KT, Müller-Berghaus G (1990) Heparin stimulates fibrinolysis in mesothelial cells by selective induction of tissue-plasminogen activator but not plasminogen activator inhibitor-1 synthesis. Thromb Hemost 64:420-425
26. Graor RA, Olin WO (1989) Regional thrombolysis in peripheral arterial occlusions. In: Julian D, Kuebler W, Norris RM, Swan HJC, Collen D, Verstraete M (eds): Thrombolysis in Cardiovascular Disease. Dekker, New York, pp 381-395